These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17951016)

  • 1. An investigation of the thermodynamic miscibility between VeTPGS and polymers.
    Li J; Chiappetta D
    Int J Pharm; 2008 Feb; 350(1-2):212-9. PubMed ID: 17951016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
    Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of phase diagrams and physical stability of drug-polymer solid dispersions.
    Lu J; Shah S; Jo S; Majumdar S; Gryczke A; Kolter K; Langley N; Repka MA
    Pharm Dev Technol; 2015 Jan; 20(1):105-17. PubMed ID: 25113671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic study of solubility enhancement of nifedipine using vitamin E TPGS or solutol HS-15.
    Rajebahadur M; Zia H; Nues A; Lee C
    Drug Deliv; 2006; 13(3):201-6. PubMed ID: 16556572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and Validation of Binary Phase Diagram for Amorphous Solid Dispersion Using Flory-Huggins Theory.
    Bansal K; Baghel US; Thakral S
    AAPS PharmSciTech; 2016 Apr; 17(2):318-27. PubMed ID: 26092302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems.
    Meng F; Dave V; Chauhan H
    Eur J Pharm Sci; 2015 Sep; 77():106-11. PubMed ID: 26006307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
    Marsac PJ; Shamblin SL; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA; Neau SH
    Drug Dev Ind Pharm; 2016 Mar; 42(3):446-455. PubMed ID: 26266965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram.
    Pajula K; Taskinen M; Lehto VP; Ketolainen J; Korhonen O
    Mol Pharm; 2010 Jun; 7(3):795-804. PubMed ID: 20361760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.
    Djuris J; Nikolakakis I; Ibric S; Djuric Z; Kachrimanis K
    Eur J Pharm Biopharm; 2013 May; 84(1):228-37. PubMed ID: 23333900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
    Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
    J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
    Altamimi MA; Neau SH
    Drug Dev Ind Pharm; 2016; 42(3):446-55. PubMed ID: 26289001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Extrusion Spheronization Approach to Enable a High Drug Load Formulation of a Poorly Soluble Drug with a Low Melting Surfactant.
    Tatavarti A; Kesisoglou F
    J Pharm Sci; 2015 Nov; 104(11):3752-3759. PubMed ID: 26205160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of drug-polymer miscibility through the use of solubility parameter based Flory-Huggins interaction parameter and the experimental validation: PEG as model polymer.
    Thakral S; Thakral NK
    J Pharm Sci; 2013 Jul; 102(7):2254-63. PubMed ID: 23649486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate.
    Parikh T; Gupta SS; Meena AK; Vitez I; Mahajan N; Serajuddin AT
    J Pharm Sci; 2015 Jul; 104(7):2142-52. PubMed ID: 25917333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical characterization of solid dispersion of furosemide with TPGS.
    Shin SC; Kim J
    Int J Pharm; 2003 Jan; 251(1-2):79-84. PubMed ID: 12527177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling as a predictive tool for the development of solid dispersions.
    Maniruzzaman M; Pang J; Morgan DJ; Douroumis D
    Mol Pharm; 2015 Apr; 12(4):1040-9. PubMed ID: 25734898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
    Meng F; Trivino A; Prasad D; Chauhan H
    Eur J Pharm Sci; 2015 Apr; 71():12-24. PubMed ID: 25686597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.